NEXTGEN HEALTHCARE INC (NXGN) Forecast, Price Target & Analyst Ratings

NASDAQ:NXGN • US65343C1027

Current stock price

23.94 USD
+0.03 (+0.13%)
At close:
23.93 USD
-0.01 (-0.04%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEXTGEN HEALTHCARE INC (NXGN).

Forecast Snapshot

Consensus Price Target

Price Target
$24.41
+ 1.97% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jan 22, 2024
Period
Q3 / 2024
EPS Estimate
$0.28
Revenue Estimate
182.03M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
50.77%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$24.41
Upside
+ 1.97%
From current price of $23.94 to mean target of $24.41, Based on 13 analyst forecasts
Low
$24.03
Median
$24.43
High
$25.20

Price Target Revisions

1 Month
-0.11%
3 Months
16.34%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for NXGN. The average price target is 24.41 USD. This implies a price increase of 1.97% is expected in the next year compared to the current price of 23.94.
The average price target has been revised upward by 16.34% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NXGN Current Analyst RatingNXGN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

NXGN Historical Analyst RatingsNXGN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
50.77%
NXGN was analyzed by 13 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about NXGN.
In the previous month the buy percentage consensus was at a similar level.
NXGN was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-09-08Truist SecuritiesMaintains Hold -> Hold
2023-09-07RBC CapitalMaintains Sector Perform -> Sector Perform
2023-08-28Cantor FitzgeraldInitiate Overweight
2023-07-25GuggenheimReiterate Buy -> Buy
2023-07-25RBC CapitalReiterate Sector Perform -> Sector Perform
2023-07-25Stephens & Co.Reiterate Overweight -> Overweight
2023-06-12RBC CapitalMaintains Sector Perform -> Sector Perform
2023-05-23GuggenheimMaintains Buy -> Buy
2023-05-22Truist SecuritiesMaintains Hold -> Hold
2023-05-18Piper SandlerMaintains Neutral -> Neutral
2023-05-17Stephens & Co.Reiterate Overweight -> Overweight
2023-04-12Stephens & Co.Initiate Overweight
2022-10-26SVB LeerinkMaintains Outperform
2022-09-07Truist SecuritiesInitiate Hold
2022-05-06GuggenheimUpgrade Neutral -> Buy
2022-05-04SVB LeerinkMaintains Outperform
2022-04-14GuggenheimInitiate Neutral
2022-01-06SVB LeerinkUpgrade Market Perform -> Outperform
2021-07-30RBC CapitalMaintains Sector Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jan 22, 2024
Period
Q3 / 2024
EPS Estimate
$0.28
Revenue Estimate
182.03M
Revenue Q2Q
12.45%
EPS Q2Q
7.23%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
0.33%
Revenue (3 Months)
-0.10%
EPS (1 Month)
-2.38%
EPS (3 Months)
-0.97%

Next Earnings Summary

NXGN is expected to report earnings on 1/22/2024. The consensus EPS estimate for the next earnings is 0.28 USD and the consensus revenue estimate is 182.03M USD.
The next earnings revenue estimate has been revised downward by 0.1% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
NXGN revenue by date.NXGN revenue by date.
556.8M
3.07%		596.35M
7.10%		653.172M
9.53%		732.42M
12.13%		785.66M
7.27%		839.25M
6.82%		895.87M
6.75%		957.17M
6.84%		1.024B
6.98%		1.095B
6.93%
EBITDA
YoY % growth
NXGN ebitda by date.NXGN ebitda by date.
70.1M
3.09%		53.418M
-23.80%		38.464M
-27.99%		125.38M
225.97%		147.02M
17.26%		175.51M
19.38%		198.9M
13.33%		220.83M
11.03%		244.8M
10.85%		270.71M
10.58%
EBIT
YoY % growth
NXGN ebit by date.NXGN ebit by date.
20.9M
3.47%		11.103M
-46.88%		1.77M
-84.06%		100.11M
5,555.93%		120.59M
20.46%		142.55M
18.21%		164.02M
15.06%		183.5M
11.88%		204.82M
11.62%		228.07M
11.35%
Operating Margin
NXGN operating margin by date.NXGN operating margin by date.
3.75%1.86%0.27%13.67%15.35%16.99%18.31%19.17%20.00%20.83%
EPS
YoY % growth
NXGN eps by date.NXGN eps by date.
0.98
18.07%		0.97
-1.02%		0.98
1.03%		1.12
14.49%		1.36
21.27%		1.58
16.19%		1.94
22.58%		2.16
11.58%		2.42
11.79%		2.69
11.39%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.28
7.23%		0.30
-4.58%		0.30
26.08%		0.32
2.00%		0.35
27.14%		0.38
28.45%		0.37
21.35%		0.34
6.45%		0.40
12.23%		0.43
12.75%
Revenue
Q2Q % growth		182.03M
12.45%		189.39M
6.07%		194.84M
9.33%		192.95M
9.37%		194.16M
6.66%		203.25M
7.32%		206.54M
6.00%		207.15M
7.36%		204.65M
5.40%		216.39M
6.46%
EBITDA
Q2Q % growth		32.575M
-11.11%		35.113M
112.50%		35.454M
88.45%		36.783M
36.99%		37.066M
13.79%		40.454M
15.21%		41.045M
15.77%		40.952M
11.33%		43.782M
18.12%		46.331M
14.53%
EBIT
Q2Q % growth		25.081M
155.64%		27.452M
236.10%		27.751M
191.66%		29.049M
252.66%		30.606M
22.03%		33.93M
23.60%		32.89M
18.52%		32.774M
12.82%		35.6M
16.32%		37.68M
11.05%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NXGN Yearly Revenue VS EstimatesNXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
NXGN Yearly EPS VS EstimatesNXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.28%
EPS Next 5 Year
17.15%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.41%
Revenue Next 5 Year
7.76%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
27.47%
EBIT Next 5 Year
21.11%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NEXTGEN HEALTHCARE INC / NXGN Forecast FAQ

Can you provide the average price target for NEXTGEN HEALTHCARE INC stock?

13 analysts have analysed NXGN and the average price target is 24.41 USD. This implies a price increase of 1.97% is expected in the next year compared to the current price of 23.94.

Can you provide the upcoming earnings date for NEXTGEN HEALTHCARE INC?

NEXTGEN HEALTHCARE INC (NXGN) will report earnings on 2024-01-22, after the market close.

Can you provide the consensus estimates for NEXTGEN HEALTHCARE INC next earnings?

The consensus EPS estimate for the next earnings of NEXTGEN HEALTHCARE INC (NXGN) is 0.28 USD and the consensus revenue estimate is 182.03M USD.

What is the expected long term growth rate for NXGN stock?

The expected long term growth rate for NEXTGEN HEALTHCARE INC (NXGN) is 8.41%.